Factors associated with attending the national cancer screening program for liver cancer in korea

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 2, 2012, Pages 731-736

  Noh, Dai Keun ^a   Choi, Kui Son ^a   Jun, Jae Kwan ^a   Lee, Hoo Yeon ^b   Park, Eun Cheol ^c  

^a National Cancer Center   (South Korea)

^b Dankook University   (South Korea)

^c Yonsei University   (South Korea)

Author keywords

Factors; Korea; Liver cancer; Participation rate; Positivity rate; Screening

Indexed keywords

ADULT; AGED; ARTICLE; EARLY DIAGNOSIS; FEMALE; HUMAN; LIVER TUMOR; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PROGNOSIS; PUBLIC HEALTH; RISK FACTOR; SOUTH KOREA; SURVIVAL RATE; UTILIZATION REVIEW;

ADULT; AGED; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PATIENT PARTICIPATION; PROGNOSIS; REPUBLIC OF KOREA; RISK FACTORS; SURVIVAL RATE;

EID: 85047687171     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.2.731     Document Type: Article

References (22)

1. Ando E, Kuromatsu R, Tanaka M, et al. (2006). Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease. J Clin Gastroenterol, 40, 942-8.
2. Benvegnu L, Fattovich G, Noventa F, et al. (1994). Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer, 74, 2442-8.
3. Boyle P, Levin B (Eds) (2008). World cancer report 2008, International Agency for Research on Cancer, Lyon.
4. Chen TH, Chen CJ, Yen MF, et al. (2002). Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan. Int J Cancer, 98, 257-61.
5. Colombo M, Kuo G, Choo QL, et al. (1989). Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet, 2, 1006-8.
6. Daniele B, Bencivenga A, Megna AS, et al. (2004). Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology, 127, S108-12.
7. Farmer MM, Bastani R, Kwan L, et al. (2008). Predictors of colorectal cancer screening from patients enrolled in a managed care health plan. Cancer, 112, 1230-8.
8. Ferlay J, Shin H, Bray F, et al. (2010). GLOBALCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 [internet]. Lyon, france: International Agency for Research on Cancer.
9. Han KH, Park JW (2002). The usefulness and current status of the screening program for early diagnosis of hepatocellular carcinoma. J Korean Med Assoc, 45, 972-80.
10. Jung KW, Park S, Kong HJ, et al. (2010). Cancer statistics in Korea: incidence, mortality and survival in 2006-2007. J Korean Med Sci, 25, 1113-21.
11. Kato Y, Nakata K, Omagari K, et al. (1994). Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer, 74, 2234-8.
12. Kim CW, Lee SY, Moon OR (2008). Inequalities in cancer incidence and mortality across income groups and policy implications in South Korea. Public Health, 122, 229-36.
13. Lee EH, Han MA, Lee HY, et al. (2010). Liver cancer screening in Korea: a report on the 2008 National Cancer Screening Programme. Asian Pac J Cancer Prev, 11, 1305-10.
14. Meissner HI, Breen N, Klabunde CN, et al. (2006). Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev, 15, 389-94.
15. Ministry of Health & Welfare, National Cancer Center (2010). Cancer facts & figures 2010 in the republic of Korea. In. Goyang, Korea: National Cancer Center.
16. NHS Cancer Screening Programmes (2010a). NHS breast screening programme annual review 2010 [Internet]. In. Sheffield: NHS Cancer Screening Programmes.
17. NHS Cancer Screening Programmes (2010b). NHS cervical screening programme annual review 2010 [Internet]. In. Sheffield: NHS Cancer Screening Programmes.
18. Oka H, Tamori A, Kuroki T, et al. (1994). Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology, 19, 61-6.
19. Sangiovanni A, Del Ninno E, Fasani P, et al. (2004). Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology, 126, 1005-14.
20. Won YJ, Sung J, Jung KW, et al. (2009). Nationwide cancer incidence in Korea, 2003-2005. Cancer Res Treat, 41, 122-31.
21. Yoo KY (2008). Cancer control activities in the Republic of Korea. Jpn J Clin Oncol, 38, 327-33.
22. Zhang BH, Yang BH, Tang ZY (2004). Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol, 130, 417-22.